Skip to main content

Advertisement

Log in

ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population

  • Original Article
  • Published:
Clinical and Experimental Medicine Aims and scope Submit manuscript

Abstract

Apolipoprotein E is a fundamental component of various lipoproteins and plays substantial role in cholesterol/lipid transport among cells of various tissues. The ApoE gene is polymorphic with three alleles ε2, ε3, and ε4, coding for isoforms E2, E3, and E4 having different binding inclination for corresponding receptors. This work aimed to investigate the association between ApoE gene polymorphism and coronary artery disease (CAD) in Kashmiri population. APOE genotyping was done by polymerase chain reaction-restriction fragment length polymorphism. Our study indicated ApoE ε3/ε3 to be the most common genotype in both CAD and control group. The frequency of ε2, ε3, and ε4 alleles of ApoE gene in cases was observed to be 0.06, 0.72, and 0.20, while in control subjects it was 0.075, 0.82, and 0.11, respectively. A significant difference was found between cases and controls with respect to TC, LDL, and HDL levels. Our data showed that frequency of ε4/ε4, ε4/ε3 genotype and ε4 allele was significantly higher in cases than in controls (p = 0.02, p = 0.004, p < 0.001 respectively). Moreover, the CAD patients carrying ε4 allele had significantly higher TC and LDL levels (p value <0.01). Thus our data showed a significant association of ApoE ε4 allele with the risk of CAD. The data revealed that ApoE ε4 allele is associated with increased risk of CAD and increased levels LDL and TC in Kashmiri population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. World Health Organization. The World Health Report 2007: global public health security in the 21st century, 2007.

  2. Joshi P, Islam S, Pais P, et al. Risk factors for early myocardial infarction in South Asians compared with individuals in other countries. J Am Med Assoc. 2007;297(3):286–94.

    CAS  Google Scholar 

  3. Mahley RW. Apo lipoprotein E: cholesterol transport protein with expending role in cell. Science. 1988;240:622–30.

    CAS  PubMed  Google Scholar 

  4. Winkelmann BR, Hager J. Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics. 2000;1:73–94.

    CAS  PubMed  Google Scholar 

  5. Dimitrios N, Tziakas MD, Georgios K, Chalikias MD, Christos O, Antonoglou MD, Stavroula V, Ioannis KT, Alexandros XK, Dimitrios IH, Juan CK. Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease. J Am Coll Cardiol. 2006;48(12):2471–81.

    Google Scholar 

  6. Rall SC Jr, Mahley RW. The role of apolipoprotein E genetic variants in lipoprotein disorders. J Intern Med. 1992;231:653–9.

    CAS  PubMed  Google Scholar 

  7. Kuusisto J, Mykkänen L, Kervinen K, Kesäniemi YA, Laakso M. Apolipoprotein E4 phenotype is not an important risk factor for coronary heart disease or stroke in elderly subjects. Arterioscler Thromb Vasc Biol. 1995;15:1280–6.

    CAS  PubMed  Google Scholar 

  8. Heish WJ, Sing-Ka L, Ming-Shien W, Tseun KJ. Characterisation of apolipoprotein E genetic variations in Taiwanese: association with coronary heart disease and plasma lipid levels. Hum Biol. 2002;5:1–3.

    Google Scholar 

  9. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 1988;8:1–21.

    CAS  PubMed  Google Scholar 

  10. Stokic E, Dan I, Plecas A, Dan M, Obreht D. Distribution of e4 allele of apoE gene in patients with metabolic syndrome, obesity and CHD. In: Book of abstracts of 2nd symposium on hyperlipoproteinemia, 98. Serbian Medical Society, Medical Society of Vojvodina, 2008.

  11. Koch W, Mehilli J, Pfeufer A, Schömig A, Kastrati A. Apolipoprotein E gene polymorphisms and thrombosis and restenosis after coronary artery stenting. J Lipid Res. 2004;45:2221–6.

    CAS  PubMed  Google Scholar 

  12. Abu Marzzouk LF, Sharif FA, Abed AA. Relationship between ApoE gene polymorphism and coronary heart disease in Gaza strip. J Cardiovasc Dis Res. 2012;2:29–35.

    Google Scholar 

  13. Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC. Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002;155:487–95.

    PubMed  Google Scholar 

  14. Djan I, Stokic E, Sakac D, Djan M, Obreht D, Erak M, Jovanoic N. Case–control study of apoE gene polymorphisms in young CHD patients and controls in the Serbian population. Arch Boil Sci Belgrade. 2011;63:89–98.

    Google Scholar 

  15. Yousuf Adfar, Khursheed Nayil, Rasool Ishrat, Kundal Vijay, Jeelani Humira, Afroze Dil. Genetic variation of ApoE gene in ethnic Kashmiri population and its association with outcome after Traumatic brain injury. J Mol Neurosci. 2015. doi:10.1007/s12031-015-0554-1.

    PubMed  Google Scholar 

  16. Breslow JC. Apolypoprotein genetic variation and human disease. Physiol Rev. 1988;68:85–98.

    CAS  PubMed  Google Scholar 

  17. Rossouw JE. Hormones, genetic factors, and gender differences in cardiovascular disease. Cardiovasc Res. 2002;53:550–7.

    CAS  PubMed  Google Scholar 

  18. Tikkanen M, Huttunen J, Ehnholm C, et al. Apolipoprotein E4 homozygosity predisposes to serum cholesterol elevation during high fat diet. Arteirosclerosis. 1990;10:285–8.

    CAS  Google Scholar 

  19. Ilveskoski E, Loimaala A, Mercuri MF, et al. Apolipoprotein E polymorphism and carotid artery intima-media thickness in a random sample of middle-aged men. Atherosclerosis. 2000;153:147–53.

    CAS  PubMed  Google Scholar 

  20. Howard BV, Gidding SS, Liu K. Association of apolipoprotein E phenotype with plasma lipoproteins in African-American and white young adults. The CARDIA study. Coronary Artery Risk Development in young adults. Am J Epidemiol. 1998;148:859–68.

    CAS  PubMed  Google Scholar 

  21. Corbo RM, Scacchi R. Apolipoprotein E (APOE) allele distribution in the world. Is APOE*4 a ‘thrifty’ allele? Ann Hum Genet. 1999;63:301–10.

    CAS  PubMed  Google Scholar 

  22. Wilson PW, Schaefer EJ, Larson MG, Ordovas JM. Apolipoprotein E alleles and risk of coronary disease. A meta-analysis. Arterioscler Thromb Vasc Biol. 1996;16:1250–5.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We gratefully acknowledge all the CAD patients and healthy blood donors who have participated in this study.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dil Afroze.

Ethics declarations

Conflict of interest

None.

Additional information

Dil Afroze and Adfar Yousuf have equally contributed to this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Afroze, D., Yousuf, A., Tramboo, N. et al. ApoE gene polymorphism and its relationship with coronary artery disease in ethnic Kashmiri population. Clin Exp Med 16, 551–556 (2016). https://doi.org/10.1007/s10238-015-0389-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10238-015-0389-7

Keywords

Navigation